Skip to main content
Clinical Trials/NCT04100343
NCT04100343
Unknown
N/A

Detection of Pattern of Unusual Signs and Symptoms of Multiple Sclerosis

Assiut University0 sites100 target enrollmentNovember 1, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
Fatigue severity scale
Last Updated
6 years ago

Overview

Brief Summary

Each Multiple Sclerosis patient will be submitted to Cognitive Abilities Screening Instrument (CASI), Expanded Disability Status Scale, Epowrth Sleeping Scale(ESS),Fatigue Severity Scale(FSS), Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Headache Disability Index, specific questionnaire based on International Headache Society (IHS) recommendations

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
December 1, 2021
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mahmood Mohammed Yosry Abdelsatar Mohammed

Mahmood M. Yosry Abdelsatar

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Male or female.
  • Age:30-50 years
  • Accepting all study requirement

Exclusion Criteria

  • comorbid patient e.g (diabetic, hypertensive.......etc )
  • opposition of the patient or their family

Outcomes

Primary Outcomes

Fatigue severity scale

Time Frame: 1 year

A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63. The higher the score, the more severe the fatigue is and the more it affects the person's activities. It is simple to understand and takes an average of eight minutes to answer

Similar Trials